Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of Preeclampsia
- 1 September 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (9), 1702-1703
- https://doi.org/10.1373/clinchem.2004.036715
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces ProteinuriaPublished by Elsevier BV ,2003
- Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJCI Insight, 2003
- Pathogenesis and genetics of pre-eclampsiaThe Lancet, 2001